nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—ABCB1—colon cancer	0.384	1	CbGaD
Fentanyl—CYP3A7—Irinotecan—colon cancer	0.058	0.145	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.058	0.145	CbGbCtD
Fentanyl—CYP3A7—Vincristine—colon cancer	0.0507	0.127	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0507	0.127	CbGbCtD
Fentanyl—CYP3A5—Irinotecan—colon cancer	0.0435	0.109	CbGbCtD
Fentanyl—CYP3A5—Vincristine—colon cancer	0.038	0.0954	CbGbCtD
Fentanyl—ABCB1—Irinotecan—colon cancer	0.0283	0.071	CbGbCtD
Fentanyl—ABCB1—Vincristine—colon cancer	0.0248	0.0621	CbGbCtD
Fentanyl—CYP3A4—Irinotecan—colon cancer	0.017	0.0425	CbGbCtD
Fentanyl—ABCB1—Methotrexate—colon cancer	0.015	0.0376	CbGbCtD
Fentanyl—CYP3A4—Vincristine—colon cancer	0.0148	0.0372	CbGbCtD
Fentanyl—Alfentanil—ABCB1—colon cancer	0.000421	0.23	CrCbGaD
Fentanyl—Astemizole—ABCB1—colon cancer	0.000328	0.179	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—colon cancer	0.000237	0.129	CrCbGaD
Fentanyl—Fexofenadine—ABCB1—colon cancer	0.000233	0.128	CrCbGaD
Fentanyl—Propafenone—ABCB1—colon cancer	0.000188	0.103	CrCbGaD
Fentanyl—Bepridil—ABCB1—colon cancer	0.000168	0.0917	CrCbGaD
Fentanyl—Hyperhidrosis—Irinotecan—colon cancer	0.000163	0.000754	CcSEcCtD
Fentanyl—Confusional state—Fluorouracil—colon cancer	0.000162	0.000753	CcSEcCtD
Fentanyl—Mood swings—Methotrexate—colon cancer	0.000161	0.000749	CcSEcCtD
Fentanyl—Hypotension—Vincristine—colon cancer	0.000161	0.000748	CcSEcCtD
Fentanyl—Bradycardia—Capecitabine—colon cancer	0.000161	0.000748	CcSEcCtD
Fentanyl—Oedema—Fluorouracil—colon cancer	0.000161	0.000747	CcSEcCtD
Fentanyl—Anaphylactic shock—Fluorouracil—colon cancer	0.000161	0.000747	CcSEcCtD
Fentanyl—Anorexia—Irinotecan—colon cancer	0.00016	0.000743	CcSEcCtD
Fentanyl—Infection—Fluorouracil—colon cancer	0.00016	0.000742	CcSEcCtD
Fentanyl—Haemoglobin—Capecitabine—colon cancer	0.000159	0.000739	CcSEcCtD
Fentanyl—Rhinitis—Capecitabine—colon cancer	0.000159	0.000737	CcSEcCtD
Fentanyl—Haemorrhage—Capecitabine—colon cancer	0.000158	0.000735	CcSEcCtD
Fentanyl—Nervous system disorder—Fluorouracil—colon cancer	0.000158	0.000733	CcSEcCtD
Fentanyl—Thrombocytopenia—Fluorouracil—colon cancer	0.000158	0.000731	CcSEcCtD
Fentanyl—Hypoaesthesia—Capecitabine—colon cancer	0.000158	0.000731	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Vincristine—colon cancer	0.000157	0.00073	CcSEcCtD
Fentanyl—Pharyngitis—Capecitabine—colon cancer	0.000157	0.000729	CcSEcCtD
Fentanyl—Tachycardia—Fluorouracil—colon cancer	0.000157	0.000729	CcSEcCtD
Fentanyl—Hypotension—Irinotecan—colon cancer	0.000157	0.000729	CcSEcCtD
Fentanyl—Urinary tract disorder—Capecitabine—colon cancer	0.000156	0.000726	CcSEcCtD
Fentanyl—Insomnia—Vincristine—colon cancer	0.000156	0.000724	CcSEcCtD
Fentanyl—Oedema peripheral—Capecitabine—colon cancer	0.000156	0.000724	CcSEcCtD
Fentanyl—Connective tissue disorder—Capecitabine—colon cancer	0.000156	0.000722	CcSEcCtD
Fentanyl—Urethral disorder—Capecitabine—colon cancer	0.000155	0.00072	CcSEcCtD
Fentanyl—Paraesthesia—Vincristine—colon cancer	0.000155	0.000719	CcSEcCtD
Fentanyl—Breast disorder—Methotrexate—colon cancer	0.000154	0.000714	CcSEcCtD
Fentanyl—Anorexia—Fluorouracil—colon cancer	0.000154	0.000712	CcSEcCtD
Fentanyl—Visual impairment—Capecitabine—colon cancer	0.000153	0.000708	CcSEcCtD
Fentanyl—Insomnia—Irinotecan—colon cancer	0.000152	0.000705	CcSEcCtD
Fentanyl—Paraesthesia—Irinotecan—colon cancer	0.000151	0.0007	CcSEcCtD
Fentanyl—Hypotension—Fluorouracil—colon cancer	0.00015	0.000698	CcSEcCtD
Fentanyl—Decreased appetite—Vincristine—colon cancer	0.00015	0.000696	CcSEcCtD
Fentanyl—Dyspnoea—Irinotecan—colon cancer	0.00015	0.000695	CcSEcCtD
Fentanyl—Erythema multiforme—Capecitabine—colon cancer	0.00015	0.000695	CcSEcCtD
Fentanyl—Somnolence—Irinotecan—colon cancer	0.000149	0.000693	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Vincristine—colon cancer	0.000149	0.000691	CcSEcCtD
Fentanyl—Fatigue—Vincristine—colon cancer	0.000149	0.00069	CcSEcCtD
Fentanyl—Loperamide—ABCB1—colon cancer	0.000149	0.0812	CrCbGaD
Fentanyl—Eye disorder—Capecitabine—colon cancer	0.000148	0.000687	CcSEcCtD
Fentanyl—Dyspepsia—Irinotecan—colon cancer	0.000148	0.000687	CcSEcCtD
Fentanyl—Tinnitus—Capecitabine—colon cancer	0.000148	0.000685	CcSEcCtD
Fentanyl—Pain—Vincristine—colon cancer	0.000148	0.000685	CcSEcCtD
Fentanyl—Constipation—Vincristine—colon cancer	0.000148	0.000685	CcSEcCtD
Fentanyl—Asthma—Methotrexate—colon cancer	0.000147	0.000683	CcSEcCtD
Fentanyl—Cardiac disorder—Capecitabine—colon cancer	0.000147	0.000682	CcSEcCtD
Fentanyl—Flushing—Capecitabine—colon cancer	0.000147	0.000682	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000147	0.000681	CcSEcCtD
Fentanyl—Decreased appetite—Irinotecan—colon cancer	0.000146	0.000678	CcSEcCtD
Fentanyl—Insomnia—Fluorouracil—colon cancer	0.000146	0.000676	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Irinotecan—colon cancer	0.000145	0.000673	CcSEcCtD
Fentanyl—Fatigue—Irinotecan—colon cancer	0.000145	0.000672	CcSEcCtD
Fentanyl—Paraesthesia—Fluorouracil—colon cancer	0.000145	0.000671	CcSEcCtD
Fentanyl—Constipation—Irinotecan—colon cancer	0.000144	0.000667	CcSEcCtD
Fentanyl—Pain—Irinotecan—colon cancer	0.000144	0.000667	CcSEcCtD
Fentanyl—Angiopathy—Capecitabine—colon cancer	0.000144	0.000667	CcSEcCtD
Fentanyl—Dyspnoea—Fluorouracil—colon cancer	0.000144	0.000666	CcSEcCtD
Fentanyl—Somnolence—Fluorouracil—colon cancer	0.000143	0.000664	CcSEcCtD
Fentanyl—Immune system disorder—Capecitabine—colon cancer	0.000143	0.000664	CcSEcCtD
Fentanyl—Mediastinal disorder—Capecitabine—colon cancer	0.000143	0.000662	CcSEcCtD
Fentanyl—Chills—Capecitabine—colon cancer	0.000142	0.000659	CcSEcCtD
Fentanyl—Dyspepsia—Fluorouracil—colon cancer	0.000142	0.000658	CcSEcCtD
Fentanyl—Arrhythmia—Capecitabine—colon cancer	0.000142	0.000656	CcSEcCtD
Fentanyl—Abdominal discomfort—Methotrexate—colon cancer	0.000141	0.000655	CcSEcCtD
Fentanyl—Gastrointestinal pain—Vincristine—colon cancer	0.000141	0.000655	CcSEcCtD
Fentanyl—Decreased appetite—Fluorouracil—colon cancer	0.00014	0.000649	CcSEcCtD
Fentanyl—Alopecia—Capecitabine—colon cancer	0.00014	0.000649	CcSEcCtD
Fentanyl—Pancytopenia—Methotrexate—colon cancer	0.00014	0.000649	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000139	0.000645	CcSEcCtD
Fentanyl—Mental disorder—Capecitabine—colon cancer	0.000139	0.000644	CcSEcCtD
Fentanyl—Feeling abnormal—Irinotecan—colon cancer	0.000139	0.000643	CcSEcCtD
Fentanyl—Malnutrition—Capecitabine—colon cancer	0.000138	0.00064	CcSEcCtD
Fentanyl—Erythema—Capecitabine—colon cancer	0.000138	0.00064	CcSEcCtD
Fentanyl—Dysuria—Methotrexate—colon cancer	0.000138	0.000639	CcSEcCtD
Fentanyl—Neutropenia—Methotrexate—colon cancer	0.000138	0.000639	CcSEcCtD
Fentanyl—Pain—Fluorouracil—colon cancer	0.000138	0.000639	CcSEcCtD
Fentanyl—Gastrointestinal pain—Irinotecan—colon cancer	0.000138	0.000638	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Methotrexate—colon cancer	0.000137	0.000635	CcSEcCtD
Fentanyl—Body temperature increased—Vincristine—colon cancer	0.000136	0.000633	CcSEcCtD
Fentanyl—Abdominal pain—Vincristine—colon cancer	0.000136	0.000633	CcSEcCtD
Fentanyl—Flatulence—Capecitabine—colon cancer	0.000136	0.00063	CcSEcCtD
Fentanyl—Erectile dysfunction—Methotrexate—colon cancer	0.000136	0.000629	CcSEcCtD
Fentanyl—Dysgeusia—Capecitabine—colon cancer	0.000135	0.000626	CcSEcCtD
Fentanyl—Back pain—Capecitabine—colon cancer	0.000133	0.000619	CcSEcCtD
Fentanyl—Abdominal pain—Irinotecan—colon cancer	0.000133	0.000617	CcSEcCtD
Fentanyl—Body temperature increased—Irinotecan—colon cancer	0.000133	0.000617	CcSEcCtD
Fentanyl—Feeling abnormal—Fluorouracil—colon cancer	0.000133	0.000616	CcSEcCtD
Fentanyl—Muscle spasms—Capecitabine—colon cancer	0.000133	0.000615	CcSEcCtD
Fentanyl—Pneumonia—Methotrexate—colon cancer	0.000132	0.000613	CcSEcCtD
Fentanyl—Infestation—Methotrexate—colon cancer	0.000131	0.000609	CcSEcCtD
Fentanyl—Drowsiness—Methotrexate—colon cancer	0.000131	0.000609	CcSEcCtD
Fentanyl—Infestation NOS—Methotrexate—colon cancer	0.000131	0.000609	CcSEcCtD
Fentanyl—Depression—Methotrexate—colon cancer	0.000131	0.000608	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00013	0.000604	CcSEcCtD
Fentanyl—Vision blurred—Capecitabine—colon cancer	0.00013	0.000603	CcSEcCtD
Fentanyl—Tremor—Capecitabine—colon cancer	0.000129	0.000599	CcSEcCtD
Fentanyl—Renal failure—Methotrexate—colon cancer	0.000129	0.000599	CcSEcCtD
Fentanyl—Stomatitis—Methotrexate—colon cancer	0.000128	0.000594	CcSEcCtD
Fentanyl—Ill-defined disorder—Capecitabine—colon cancer	0.000128	0.000593	CcSEcCtD
Fentanyl—Urticaria—Fluorouracil—colon cancer	0.000128	0.000593	CcSEcCtD
Fentanyl—Conjunctivitis—Methotrexate—colon cancer	0.000128	0.000592	CcSEcCtD
Fentanyl—Anaemia—Capecitabine—colon cancer	0.000127	0.000591	CcSEcCtD
Fentanyl—Body temperature increased—Fluorouracil—colon cancer	0.000127	0.000591	CcSEcCtD
Fentanyl—Hypersensitivity—Vincristine—colon cancer	0.000127	0.00059	CcSEcCtD
Fentanyl—Sweating—Methotrexate—colon cancer	0.000126	0.000584	CcSEcCtD
Fentanyl—Haematuria—Methotrexate—colon cancer	0.000125	0.000581	CcSEcCtD
Fentanyl—Malaise—Capecitabine—colon cancer	0.000124	0.000577	CcSEcCtD
Fentanyl—Hepatobiliary disease—Methotrexate—colon cancer	0.000124	0.000576	CcSEcCtD
Fentanyl—Epistaxis—Methotrexate—colon cancer	0.000124	0.000575	CcSEcCtD
Fentanyl—Vertigo—Capecitabine—colon cancer	0.000124	0.000575	CcSEcCtD
Fentanyl—Hypersensitivity—Irinotecan—colon cancer	0.000124	0.000575	CcSEcCtD
Fentanyl—Asthenia—Vincristine—colon cancer	0.000124	0.000575	CcSEcCtD
Fentanyl—Syncope—Capecitabine—colon cancer	0.000124	0.000574	CcSEcCtD
Fentanyl—Leukopenia—Capecitabine—colon cancer	0.000123	0.000573	CcSEcCtD
Fentanyl—Palpitations—Capecitabine—colon cancer	0.000122	0.000565	CcSEcCtD
Fentanyl—Loss of consciousness—Capecitabine—colon cancer	0.000121	0.000562	CcSEcCtD
Fentanyl—Asthenia—Irinotecan—colon cancer	0.000121	0.00056	CcSEcCtD
Fentanyl—Cough—Capecitabine—colon cancer	0.00012	0.000558	CcSEcCtD
Fentanyl—Hypertension—Capecitabine—colon cancer	0.000119	0.000552	CcSEcCtD
Fentanyl—Hypersensitivity—Fluorouracil—colon cancer	0.000119	0.00055	CcSEcCtD
Fentanyl—Haemoglobin—Methotrexate—colon cancer	0.000119	0.00055	CcSEcCtD
Fentanyl—Diarrhoea—Vincristine—colon cancer	0.000118	0.000548	CcSEcCtD
Fentanyl—Haemorrhage—Methotrexate—colon cancer	0.000118	0.000547	CcSEcCtD
Fentanyl—Arthralgia—Capecitabine—colon cancer	0.000117	0.000545	CcSEcCtD
Fentanyl—Myalgia—Capecitabine—colon cancer	0.000117	0.000545	CcSEcCtD
Fentanyl—Chest pain—Capecitabine—colon cancer	0.000117	0.000545	CcSEcCtD
Fentanyl—Pharyngitis—Methotrexate—colon cancer	0.000117	0.000543	CcSEcCtD
Fentanyl—Anxiety—Capecitabine—colon cancer	0.000117	0.000543	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000117	0.000541	CcSEcCtD
Fentanyl—Urinary tract disorder—Methotrexate—colon cancer	0.000116	0.00054	CcSEcCtD
Fentanyl—Discomfort—Capecitabine—colon cancer	0.000116	0.000538	CcSEcCtD
Fentanyl—Urethral disorder—Methotrexate—colon cancer	0.000116	0.000536	CcSEcCtD
Fentanyl—Diarrhoea—Irinotecan—colon cancer	0.000115	0.000534	CcSEcCtD
Fentanyl—Dry mouth—Capecitabine—colon cancer	0.000115	0.000533	CcSEcCtD
Fentanyl—Dizziness—Vincristine—colon cancer	0.000114	0.00053	CcSEcCtD
Fentanyl—Pruritus—Fluorouracil—colon cancer	0.000114	0.000529	CcSEcCtD
Fentanyl—Visual impairment—Methotrexate—colon cancer	0.000114	0.000527	CcSEcCtD
Fentanyl—Confusional state—Capecitabine—colon cancer	0.000113	0.000526	CcSEcCtD
Fentanyl—Oedema—Capecitabine—colon cancer	0.000113	0.000522	CcSEcCtD
Fentanyl—Infection—Capecitabine—colon cancer	0.000112	0.000519	CcSEcCtD
Fentanyl—Erythema multiforme—Methotrexate—colon cancer	0.000111	0.000517	CcSEcCtD
Fentanyl—Dizziness—Irinotecan—colon cancer	0.000111	0.000516	CcSEcCtD
Fentanyl—Shock—Capecitabine—colon cancer	0.000111	0.000514	CcSEcCtD
Fentanyl—Nervous system disorder—Capecitabine—colon cancer	0.00011	0.000512	CcSEcCtD
Fentanyl—Eye disorder—Methotrexate—colon cancer	0.00011	0.000511	CcSEcCtD
Fentanyl—Diarrhoea—Fluorouracil—colon cancer	0.00011	0.000511	CcSEcCtD
Fentanyl—Thrombocytopenia—Capecitabine—colon cancer	0.00011	0.000511	CcSEcCtD
Fentanyl—Tinnitus—Methotrexate—colon cancer	0.00011	0.00051	CcSEcCtD
Fentanyl—Tachycardia—Capecitabine—colon cancer	0.00011	0.000509	CcSEcCtD
Fentanyl—Vomiting—Vincristine—colon cancer	0.00011	0.000509	CcSEcCtD
Fentanyl—Cardiac disorder—Methotrexate—colon cancer	0.000109	0.000508	CcSEcCtD
Fentanyl—Skin disorder—Capecitabine—colon cancer	0.000109	0.000507	CcSEcCtD
Fentanyl—Rash—Vincristine—colon cancer	0.000109	0.000505	CcSEcCtD
Fentanyl—Hyperhidrosis—Capecitabine—colon cancer	0.000109	0.000505	CcSEcCtD
Fentanyl—Dermatitis—Vincristine—colon cancer	0.000109	0.000505	CcSEcCtD
Fentanyl—Headache—Vincristine—colon cancer	0.000108	0.000502	CcSEcCtD
Fentanyl—Anorexia—Capecitabine—colon cancer	0.000107	0.000498	CcSEcCtD
Fentanyl—Angiopathy—Methotrexate—colon cancer	0.000107	0.000496	CcSEcCtD
Fentanyl—Vomiting—Irinotecan—colon cancer	0.000107	0.000496	CcSEcCtD
Fentanyl—Immune system disorder—Methotrexate—colon cancer	0.000107	0.000494	CcSEcCtD
Fentanyl—Dizziness—Fluorouracil—colon cancer	0.000107	0.000494	CcSEcCtD
Fentanyl—Mediastinal disorder—Methotrexate—colon cancer	0.000106	0.000493	CcSEcCtD
Fentanyl—Rash—Irinotecan—colon cancer	0.000106	0.000492	CcSEcCtD
Fentanyl—Dermatitis—Irinotecan—colon cancer	0.000106	0.000491	CcSEcCtD
Fentanyl—Chills—Methotrexate—colon cancer	0.000106	0.000491	CcSEcCtD
Fentanyl—Methadone—ABCB1—colon cancer	0.000106	0.0578	CrCbGaD
Fentanyl—Headache—Irinotecan—colon cancer	0.000105	0.000489	CcSEcCtD
Fentanyl—Hypotension—Capecitabine—colon cancer	0.000105	0.000488	CcSEcCtD
Fentanyl—Alopecia—Methotrexate—colon cancer	0.000104	0.000483	CcSEcCtD
Fentanyl—Mental disorder—Methotrexate—colon cancer	0.000103	0.000479	CcSEcCtD
Fentanyl—Erythema—Methotrexate—colon cancer	0.000103	0.000476	CcSEcCtD
Fentanyl—Malnutrition—Methotrexate—colon cancer	0.000103	0.000476	CcSEcCtD
Fentanyl—Nausea—Vincristine—colon cancer	0.000103	0.000476	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000103	0.000476	CcSEcCtD
Fentanyl—Vomiting—Fluorouracil—colon cancer	0.000102	0.000475	CcSEcCtD
Fentanyl—Insomnia—Capecitabine—colon cancer	0.000102	0.000472	CcSEcCtD
Fentanyl—Rash—Fluorouracil—colon cancer	0.000102	0.000471	CcSEcCtD
Fentanyl—Dermatitis—Fluorouracil—colon cancer	0.000101	0.000471	CcSEcCtD
Fentanyl—Paraesthesia—Capecitabine—colon cancer	0.000101	0.000469	CcSEcCtD
Fentanyl—Headache—Fluorouracil—colon cancer	0.000101	0.000468	CcSEcCtD
Fentanyl—Dysgeusia—Methotrexate—colon cancer	0.000101	0.000466	CcSEcCtD
Fentanyl—Dyspnoea—Capecitabine—colon cancer	0.0001	0.000465	CcSEcCtD
Fentanyl—Nausea—Irinotecan—colon cancer	9.99e-05	0.000463	CcSEcCtD
Fentanyl—Back pain—Methotrexate—colon cancer	9.93e-05	0.000461	CcSEcCtD
Fentanyl—Dyspepsia—Capecitabine—colon cancer	9.91e-05	0.00046	CcSEcCtD
Fentanyl—Decreased appetite—Capecitabine—colon cancer	9.78e-05	0.000454	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Capecitabine—colon cancer	9.72e-05	0.000451	CcSEcCtD
Fentanyl—Fatigue—Capecitabine—colon cancer	9.7e-05	0.00045	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—colon cancer	9.67e-05	0.000449	CcSEcCtD
Fentanyl—Pain—Capecitabine—colon cancer	9.62e-05	0.000446	CcSEcCtD
Fentanyl—Constipation—Capecitabine—colon cancer	9.62e-05	0.000446	CcSEcCtD
Fentanyl—Nausea—Fluorouracil—colon cancer	9.57e-05	0.000444	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—colon cancer	9.52e-05	0.000442	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—colon cancer	9.49e-05	0.00044	CcSEcCtD
Fentanyl—Feeling abnormal—Capecitabine—colon cancer	9.27e-05	0.00043	CcSEcCtD
Fentanyl—Malaise—Methotrexate—colon cancer	9.26e-05	0.000429	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—colon cancer	9.22e-05	0.000428	CcSEcCtD
Fentanyl—Gastrointestinal pain—Capecitabine—colon cancer	9.2e-05	0.000427	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—colon cancer	9.19e-05	0.000426	CcSEcCtD
Fentanyl—Cough—Methotrexate—colon cancer	8.96e-05	0.000416	CcSEcCtD
Fentanyl—Urticaria—Capecitabine—colon cancer	8.94e-05	0.000415	CcSEcCtD
Fentanyl—Body temperature increased—Capecitabine—colon cancer	8.9e-05	0.000413	CcSEcCtD
Fentanyl—Abdominal pain—Capecitabine—colon cancer	8.9e-05	0.000413	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—colon cancer	8.89e-05	0.000413	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—colon cancer	8.74e-05	0.000405	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—colon cancer	8.74e-05	0.000405	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—colon cancer	8.74e-05	0.000405	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	8.68e-05	0.000403	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—colon cancer	8.63e-05	0.000401	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—colon cancer	8.45e-05	0.000392	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—colon cancer	8.38e-05	0.000389	CcSEcCtD
Fentanyl—Infection—Methotrexate—colon cancer	8.32e-05	0.000386	CcSEcCtD
Fentanyl—Hypersensitivity—Capecitabine—colon cancer	8.29e-05	0.000385	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—colon cancer	8.22e-05	0.000381	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—colon cancer	8.2e-05	0.00038	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—colon cancer	8.14e-05	0.000377	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—colon cancer	8.1e-05	0.000376	CcSEcCtD
Fentanyl—Asthenia—Capecitabine—colon cancer	8.07e-05	0.000375	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—colon cancer	7.99e-05	0.00037	CcSEcCtD
Fentanyl—Pruritus—Capecitabine—colon cancer	7.96e-05	0.000369	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—colon cancer	7.83e-05	0.000363	CcSEcCtD
Fentanyl—Diarrhoea—Capecitabine—colon cancer	7.7e-05	0.000357	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—colon cancer	7.63e-05	0.000354	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—colon cancer	7.58e-05	0.000351	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—colon cancer	7.52e-05	0.000349	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—colon cancer	7.47e-05	0.000346	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—colon cancer	7.45e-05	0.000345	CcSEcCtD
Fentanyl—Dizziness—Capecitabine—colon cancer	7.44e-05	0.000345	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—colon cancer	7.37e-05	0.000342	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—colon cancer	7.28e-05	0.000338	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—colon cancer	7.23e-05	0.000335	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—colon cancer	7.22e-05	0.000335	CcSEcCtD
Fentanyl—Pain—Methotrexate—colon cancer	7.16e-05	0.000332	CcSEcCtD
Fentanyl—Vomiting—Capecitabine—colon cancer	7.16e-05	0.000332	CcSEcCtD
Fentanyl—Rash—Capecitabine—colon cancer	7.1e-05	0.000329	CcSEcCtD
Fentanyl—Dermatitis—Capecitabine—colon cancer	7.09e-05	0.000329	CcSEcCtD
Fentanyl—Headache—Capecitabine—colon cancer	7.05e-05	0.000327	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—colon cancer	6.9e-05	0.00032	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—colon cancer	6.85e-05	0.000318	CcSEcCtD
Fentanyl—Nausea—Capecitabine—colon cancer	6.69e-05	0.00031	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—colon cancer	6.66e-05	0.000309	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—colon cancer	6.62e-05	0.000307	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—colon cancer	6.62e-05	0.000307	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—colon cancer	6.17e-05	0.000286	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—colon cancer	6.01e-05	0.000279	CcSEcCtD
Fentanyl—Pruritus—Methotrexate—colon cancer	5.93e-05	0.000275	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—colon cancer	5.73e-05	0.000266	CcSEcCtD
Fentanyl—Dizziness—Methotrexate—colon cancer	5.54e-05	0.000257	CcSEcCtD
Fentanyl—Vomiting—Methotrexate—colon cancer	5.33e-05	0.000247	CcSEcCtD
Fentanyl—Rash—Methotrexate—colon cancer	5.28e-05	0.000245	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—colon cancer	5.28e-05	0.000245	CcSEcCtD
Fentanyl—Headache—Methotrexate—colon cancer	5.25e-05	0.000243	CcSEcCtD
Fentanyl—Nausea—Methotrexate—colon cancer	4.98e-05	0.000231	CcSEcCtD
